The BLIND study: blinatumomab and DLI approach for management of B-ALL relapse after allogeneic stem cell transplantation. A multicentric Italian experience.
Giammarco S, Maggi R, Di Marino L, Chiusolo P, Teofili L, Piccirilo N, Metafuni E, Limongiello MA, Leotta S, Milone G, Cupri A, Cutini I, Saccardi R, Nozzoli C, Boncompagni R, Gozzini A, Scappini B, Piccini M, Fracchiolla NS, Sica S.
Giammarco S, et al. Among authors: maggi r.
Bone Marrow Transplant. 2024 Nov 21. doi: 10.1038/s41409-024-02475-0. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 39567768
No abstract available.